NSE › Healthcare

Anthem Biosciences Ltd (ANTHEM)

NSE · Healthcare · Biotechnology

₹829.85+2.55%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
₹611 cr
Revenue YoY
+26.4%
Net profit
₹190 cr
Profit YoY
+129.7%
EPS
₹1.96
EPS estimate
₹2.20
Net margin
31.1%

EPS came in at 1.96 against a street estimate of 2.20 — a miss of 10.9%.

Key statistics

Market cap
₹46,108 cr
P/E
81.1
Forward P/E
0.0
P/B
14.94
Book value
₹54.16
EPS (TTM)
₹10.12
52-week high
₹871.23
52-week low
₹577.64
50-day MA
₹769.99
200-day MA
₹703.03

Analyst view

with an average price target of ₹884.43.

Shareholding

Promoters
84.18%
Institutions
10.76%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Anthem Biosciences Ltd — free to start.

Google PlayApp Store

Other Healthcare companies

Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedCipla LimitedZydus Lifesciences LimitedLupin LimitedMax Healthcare Institute LimitedMankind Pharma LtdLaurus Labs LimitedLenskart Solutions LtdDr. Reddy's Laboratories Limited

Data updated 2026-08-05.